Amgen

Amgen cites inflation, pressure on drug prices in 450-person layoff
Amgen cites inflation, pressure on drug prices in 450-person layoff
Endpoints
Amgen
California
layoffs
Flag link:
Amgen is sued for concealing $10.7 billion tax bill from investors
Amgen is sued for concealing $10.7 billion tax bill from investors
Reuters
Amgen
taxes
legal
Puerto Rico
Flag link:
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Fierce Biotech
Volastra Therapeutics
Eli Lilly
funding
sovilnesib
Amgen
cancer
Flag link:
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Citing J&J's 'failure to comply' with court rules, judge nixes early bid to block Amgen's Stelara biosim
Fierce Pharma
JNJ
patents
Janssen
Amgen
biosimilars
Stelara
Flag link:
Could This Humira Biosimilar Be a Winner for Amgen?
Could This Humira Biosimilar Be a Winner for Amgen?
Motley Fool
Amgen
biosimilars
Amjevita
Humira
Flag link:
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Junshi's lipid lowering drug hits phase 3 goals, teeing up challenge to Amgen, Sanofi in growth market
Fierce Biotech
Junshi Biosciences
Amgen
Sanofi
China
clinical trials
PCSK9 inhibitors
Flag link:
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Fresenius Kabi introduces pegfilgrastim biosimilar for cancer patients in US
Pharmaceutical Business Review
Fresenius Kabi
Stimufend
pegfilgrastim
biosimilars
Neulasta
Amgen
cancer
Flag link:
Years after the first US biosim launches, doctors still have their concerns: survey
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
biosimilars
PBMs
physicians
AbbVie
Humira
Amgen
Amjevita
Flag link:
Amgen bond offering to help fund Horizon Therapeutics acquisition
Amgen bond offering to help fund Horizon Therapeutics acquisition
Seeking Alpha
Amgen
bond
M&A
Horizon Therapeutics
Flag link:
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Flag link:
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
Fierce Biotech
layoffs
Amgen
Merck KGaA
TCR2 Therapeutics
Moderna Therapeutics
Flag link:
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Forbes
Amgen
Amjevita
AbbVie
Humira
biosimilars
drug pricing
Flag link:
Amgen launches Humira biosimilar, releases Q4 earnings report
Amgen launches Humira biosimilar, releases Q4 earnings report
Medical Marketing and Media
Amgen
Humira
biosimilars
earnings
AbbVie
Amjevita
Flag link:
Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug
Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug
BioPharma Dive
AbbVie
Humira
biosimilars
Amgen
Flag link:
Amgen commits $8m to improve clinical trial diversity
Amgen commits $8m to improve clinical trial diversity
Outsourcing Pharma
Amgen
clinical trials
clinical trial diversity
Bristol Myers Squibb
Winn Award
Flag link:
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block
Amgen, navigating 'industry headwinds,' puts 300 commercial jobs on chopping block
Fierce Pharma
Amgen
layoffs
Flag link:
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Warren keeps pressure on pharma, this time targeting Amgen and Indivior buyouts
Fierce Pharma
Elizabeth Warren
Senate
FTC
M&A
Amgen
Horizon Therapeutics
Indivior
Opiant Pharmaceuticals
Flag link:
Amgen extends autoimmune pact with small Michigan biotech
Amgen extends autoimmune pact with small Michigan biotech
Endpoints
Amgen
autoimmune disease
Evoq Therapeutics
Flag link:
Amgen prepped to take first slice of AbbVie’s US Humira pie
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Amgen
Humira
biosimilars
adalimumab
Amjevita
Flag link:
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
NewAmsterdam's Amgen castoff cuts LDL cholesterol in phase 2, opening new front in race to market
Fierce Biotech
NewAmsterdam Pharma
Amgen
CETP inhibitors
obicetrapib
clinical trials
Flag link:

Pages